Peter A. Everts։ Platelet Phenotype May Hold the Key to More Consistent PRP Therapy
Peter A. Everts, Senior Director Medical Affairs at Bioventus, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Clinical Medicine, adding:
”We are excited to share our new review in the Journal of Clinical Medicine: ‘Are Platelet Volume, Density, and the Homeostatic Blueprint the Missing Link in Platelet-Rich Plasma Therapies?’
PRP is used in orthopedics and sports medicine on a daily basis, yet outcomes stay inconsistent.
We argue that the field has focused heavily on platelet dosing, and not as much on PRP bioformulations and platelet phenotypes.
Larger, denser, younger platelets carry far more granular content, factors that actually drive repair.
Our recommendation: measure platelet indices (MPV, PDW, density) before preparing PRP, and use protocols that recover these denser, more reactive platelets—rather than treating platelet density as a fixed value.
We present this as a grounded hypothesis: the mechanistic links are well supported, but proving that high-MPV enrichment improves outcomes awaits prospective trials. That’s the work we hope this prompts.”
Title: Are Platelet Volume, Density, and the Homeostatic Blueprint the Missing Link in Platelet-Rich Plasma Therapies? An Evidence-Based Narrative Review
Authors: Peter A. Everts, Luga Podesta, Jane Fitzpatrick, Leonardo P. Oliveira, José Fábio Lana, André van Zundert, Mikel Sánchez, Diego Delgado, Christine Brown Mahoney, Glenn Flanagan, Robert Alexander, Paul Harrison
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?